US Banks Denied Capital Relief as Fed Freezes Stress Test Buffers

Key facts

• The Federal Reserve has frozen stress capital buffers (SCBs) for U.S. banks.
• The freeze on SCBs will remain in effect until 2027.
• This decision denies banks potential capital relief.
• Analysis of the 2026 DFAST showed 23 of 30 firms had lower CET1 capital depletion.
• Lower stress test losses will not translate into capital relief for banks.
• The freeze impacts capital planning for affected institutions.

U.S. banks will not benefit from potential capital relief stemming from reduced stress test losses due to a decision by the Federal Reserve to freeze stress capital buffers (SCBs) until 2027. The Federal Reserve's action means that even though many banks saw lower capital depletion in the 2026 Dodd-Frank Act Stress Tests (DFAST), this improvement will not lead to a reduction in their required capital.

Analysis of the 2026 DFAST results indicated that 23 out of the 30 firms examined would have experienced lower common equity tier 1 (CET1) capital depletion under the current stress test scenarios. This suggests that the banks have become more resilient or that the stress test parameters have become less severe for them. However, the Federal Reserve's decision to maintain the existing SCB levels effectively negates any potential capital relief that might have arisen from these lower depletion rates.